Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Josh Marcus

White House denies Trump is the ‘well-connected’ man who gained compassionate access to obesity drug in April

Multiple White House officials are denying that President Donald Trump was the mystery patient who reportedly got early access to an experimental weight loss drug to treat severe health complications.

On Tuesday, health news site STAT reported that drug maker Eli Lilly and the Food and Drug Administration granted a 79-year-old access to retatrutide, a hotly anticipated treatment, under “compassionate use,” which allows patients with severe health issues to access experimental therapies.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.